Skip to main content
. 2016 Dec 2;6(12):e503. doi: 10.1038/bcj.2016.112

Figure 3.

Figure 3

Structures of key proteasome inhibitors. Chemical structures of select clinical and investigational proteasome inhibitors: the dipeptide boronic acid bortezomib, tetrapeptide epoxyketone carfilzomib and tripeptide epoxyketone PR-957.